ScholarIQanswers from OpenAlex & ORCID
Mark R. Middleton
ResearcherPublications, citations & collaboration network
Mark R. Middleton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark R. Middleton have?
ScholarIQindexed works
Mark R. Middleton has 752 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark R. Middleton have?
ScholarIQcitation count
Mark R. Middleton has 31,014 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark R. Middleton?
ScholarIQh-index
Mark R. Middleton has an h-index of 79 in OpenAlex.
What is the i10-index of Mark R. Middleton?
ScholarIQi10-index
Mark R. Middleton has an i10-index of 271 in OpenAlex.
What is the ORCID of Mark R. Middleton?
ScholarIQorcid
The ORCID for Mark R. Middleton is on the source record.
What is the OpenAlex record for Mark R. Middleton?
ScholarIQopenalex
The OpenAlex for Mark R. Middleton is on the source record.
What are the most-cited papers on Mark R. Middleton?
ScholarIQmost cited works
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, Roland Kaufmann, Lars Bastholt, N. Basset Seguin, Véronique Bataille, V. del Mármol, Reinhard Dummer, Catherine Harwood, Axel Hauschild, Christoph Höller, Merete Hædersdal, Josep Malvehy, Mark R. Middleton, C.A. Morton, Eduardo Nagore, Alexander Stratigos, Rolf‐Markus Szeimies, Luca Tagliaferri, Myrto Trakatelli, Iris Zalaudek, Alexander Eggermont, Jean Jacques Grob
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Paolo A. Ascierto, Michele Del Vecchio, Mario Mandalà, Helen Gogas, Ana Arance, Stéphane Dalle, C. Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion‐Sileni, Iván Márquez‐Rodas, Marcus O. Butler, Michele Maio, Mark R. Middleton, Luis de la Cruz‐Merino, Petr Arenberger, Victoria Atkinson, Andrew Hill, Leslie A. Fecher, Michael Millward, Nikhil I. Khushalani, Paola Queirolo, Maurice Lobo, Veerle de Pril, John T. Loffredo, James Larkin, Jeffrey S. Weber
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Célèste Lebbé, Josep Malvehy, V. del Mármol, Hubert Pehamberger, Ketty Peris, Jürgen C. Becker, Iris Zalaudek, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Alessandro Testori, Jean‐Jacques Grob
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
Célèste Lebbé, Jürgen C. Becker, Jean‐Jacques Grob, Josep Malvehy, V. del Mármol, Hubert Pehamberger, Ketty Peris, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Alessandro Testori, Alexander Stratigos, Claus Garbe